Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Save to My Library
Look up keyword
Like this
3Activity
0 of .
Results for:
No results containing your search query
P. 1
A Timeline of Maria Cino’s Lobbying Work for Pfizer/Obamacare

A Timeline of Maria Cino’s Lobbying Work for Pfizer/Obamacare

Ratings: (0)|Views: 595 |Likes:
Published by Brooks Bayne
Timeline of Cino's lobbying work for Pfizer.
Timeline of Cino's lobbying work for Pfizer.

More info:

Published by: Brooks Bayne on Jan 13, 2011
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

05/12/2014

text

 
1
QUICK HITS: Maria Cino’s Lobbying Work for Pfizer
BOTTOM LINE:
Shortly after Pfizer and other drug companies struck a controversial $80 billion deal with theObama administration in June 2009 on ObamaCare, Cino went to work as the vice president of governmentaffairs for Pfizer, whose CEO, Jeffrey Kindler, was arguably the most vocal industry advocate of Obama’sefforts. From July 2009 – June 2010, Cino was 1 of 7 Pfizer lobbyists who pressed legislators, federal agenciesand the Executive Office of the President on “health issues,” including the ObamaCare legislation that wasapproved by the Democrat-controlled House and Senate and was subsequently signed into law by Obama.During that time, Cino’s sole focus was on such “health issues.”
BACKGROUND ON PFIZER’S PUSH FOR OBAMACARE:
Fortune 500 execs could stand up for a freemarket that benefits consumers and shareholders, or hitch their cart to the new Democratic majority. Pfizer'sMr. Kindler is a case study in the hitch-and-hope mentality—a CEO who became the motivating force behindBig Pharma's $80 billion "deal" on reform, and industry support of ObamaCare. . . . The strategy: The industrywould pledge $80 billion to reform. In return it would get greater volume and a requirement that people buybrand-name drugs. Democrats would also fight against drug reimportation and forgo price controls. No onepushed harder than Mr. Kindler. The CEO made no fewer than five trips to the White House last year. He wasthe man prodding Pharmaceutical Researchers and Manufacturers of America head Billy Tauzin every step. Hewrote an op-ed with the SEIU's Mr. Stern demanding reform. He pressed the industry's $150 million adcampaign promoting ObamaCare, rolled out with liberal activist groups.
(Kim Strassel, The Wall Street Journal, February 12, 2010)
TIMELINE OF CINO’S LOBBYING WORK FOR PFIZER:
o
 
June 22, 2009:
Media outlets report the drug industry, including Pfizer, struck an $80 billion deal with the Obamaadministration to expedite the president’s push for a health care overhaul.
 
(The Associated Press, June 22, 2009)
o
 
July 1 – Sept. 30, 2009:
On Oct. 20, Pfizer filed its 3
rd
Quarter (July 1 – Sept. 30) federal lobbying report, whichmarked the first reference of Cino’s work for the company. On pg. 4, Cino is listed as 1 of 7 lobbyists who worked on“health issues,” which included “health reform,” “health information technology,” “comparative effectivenessresearch” and “veterans healthcare issues.” In an addendum on pg. 5, Pfizer disclosed that its “health issues” team,which included Cino, lobbied on “health care reform proposals,” Obama’s stimulus plan and Democrat budgetresolutions, among other issues. Cino, who worked exclusively on health issues, and her colleagues lobbied theHouse, the Senate, the Executive Office of the President, Health & Human Services and the Food & DrugAdministration.
 
(Secretary of the U.S. Senate, Pfizer’s 3
rd
Quarter 2009 Lobbying Report, Filed October 20, 2009)
o
 
Oct. 1 – Dec. 31, 2009:
According to Pfizer’s 4
th
Quarter (Oct. 1 – Dec. 31) lobbying report, the “health issues” team,which included Cino, continued to lobby the same offices and agencies on “health issues.” An addendum on pg. 5disclosed that Cino’s team specifically lobbied on both the House- and Senate-approved health care overhaullegislation – HR 3962 and HR 3590.
(Secretary of the U.S. Senate, Pfizer’s 4
th
Quarter 2009 Lobbying Report, Filed January 25, 2010)
o
 
Feb. 5, 2010:
The New York Times
reported Cino’s boss, CEO Kindler, backed the Senate-approved bill, HR 3590.
 
[Many drug companies] basically endorsed the Senate bill. Just last month … Pfizer's chief executive, Jeffrey B.Kindler, told analysts that the Senate health care bill was ''largely consistent with the principles'' that were important to his industry.
 
(The New York Times, February 5, 2010)
o
 
Jan. 1 – March 31, 2010:
According to Pfizer’s 1
st
Quarter (Jan. 1 – March 31) lobbying report, the “health issues”team, which included Cino, continued to lobby the same offices and agencies on “health issues.” An addendum on pg.5 disclosed that Cino’s team specifically lobbied on both the House- and Senate-approved health care overhaullegislation – HR 3962 and HR 3590. On March 23, Obama signed the health care overhaul into law.
 
(Secretary of the U.S.Senate, Pfizer’s 1
st
Quarter 2010 Lobbying Report, Filed April 20, 2010; CNN, March 23, 2010)
o
 
Apr. 1 – June 30, 2010:
According to Pfizer’s 2
nd
Quarter (Apr. 1 – June 30) lobbying report, the “health issues”team, which included Cino, continued to lobby the same offices and agencies on “health issues.” An addendum on pg.5 disclosed that Cino’s team specifically lobbied on both the House- and Senate-approved health care overhaullegislation – HR 3962 and HR 3590.
 
(Secretary of the U.S. Senate, Pfizer’s 2
nd
Quarter 2010 Lobbying Report, Filed July 20, 2010)
 

Activity (3)

You've already reviewed this. Edit your review.
1 thousand reads
1 hundred reads

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->